News: UBI German stocks - Factors to watch on December 30

BERLIN/FRANKFURT, Dec 30 (Reuters) - The following are some of the factors that may move German stocks on Wednesday:

CORONAVIRUS The number of confirmed coronavirus cases in Germany increased by 22,459 to 1,687,185, data from the Robert Koch Institute (RKI) for infectious diseases showed on Wednesday. The reported death toll rose by 1,129 to 32,107, the tally showed.

The European Medicines Agency (EMA) expects an application from vaccine manufacturer BioNTech BNTX.O for the approval of extracting six vaccine doses per ampule, an EMA spokeswoman told Bild newspaper.

Germany could offer shots against the coronavirus to all who want them by the summer if a third vaccine from either Johnson & Johnson, AstraZeneca AZN.L or CureVac CVAC.O wins EU approval, Health Minister Jens Spahn said on Tuesday.

BAYER BAYGn.DE Australia's portable medical device maker Universal Biosensors Inc (UBI) said its Canadian subsidiary signed a deal with Bayer to provide services relating to performance of laboratory analysis of biological samples.

UNIPER UN01.DE The energy company wants to operate its hard coal-fired power plant in Datteln until 2038. "Datteln will be the last coal-fired power plant in Germany to go offline. We want to let Datteln run until 2038," Uniper CEO Andreas Schierenbeck told the Rheinische Post newspaper.

Schierenbeck also said he expected the Nord Stream 2 pipeline to be completed quickly. "There are only around 150 kilometers left," he said.

OVERSEAS STOCK MARKETS Dow Jones .DJI -0.2%, S&P 500 .SPX -0.2%, Nasdaq .IXIC -0.4% at close.

Nikkei .N225 -0.2%, Shanghai stocks .SSEC +0.6%.

Time: 5:59 GMT

GERMAN ECONOMIC DATA No major economic data scheduled.

DIARIES REUTERS TOP NEWS